Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Akeso, Atossa, Bioxcel, Bpgbio, Capricor, Celcuity, Cogent, Daiichi, Dyne, Eli Lilly, Immunitybio, Iregene, Lantern, Mesoblast, Nanoscope, Novartis, Organon, Rein, Valneva.